- Preview Available
- Scholarly Journal
Analysis of SARS-CoV-2 Emergent Variants Following AZD7442 (Tixagevimab/Cilgavimab) for Early Outpatient Treatment of COVID-19 (TACKLE Trial)
Infectious Diseases and Therapy; Philadelphia Vol. 12, Iss. 12, (Dec 2023): 2691-2707.
DOI:10.1007/s40121-023-00882-2
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.